Ann: AnteoTech $6.4m Capital Raising, page-259

First 259 Last

Share
Profile

Follow
prodigy1

1,186 Posts.

149

14/04/24

13:20

Post #: 73336300
Share

Originally posted by Pasqual: ↑

Hope your kids win Wayne....alot more fun in winning than just trying.....

I have to disagree with with alot being said about the under performance of the board...

We've lost 9 months with the Ferro saga and yet the board has been the only one since my ownership in 15 years to have generated an actual sale....albeit 250k from India serum labs..

They've only had a 9 month window to secure a deal whilst cleaning The mess left behind which is not to be underestimated...

Do you really think there's a better board out there??

I'm backing these guys 150% because they've been the best since I came on board.

Many need to take a break from this forum...its doing no good to your mental well-being...

Trust the board when they say we are on the cusp of completing significant commercial deals.

Trust that the government will throw grants to ADO.

In 15 years we have never been better placed.

That 50c price was all based on huff and puff...
Everything in 21/22 was overpriced...shares, property, classic cars...you name it.

Take this opportunity to steal some more shares at 2.5c, sit back and enjoy..

Focus on Now!!

Ps Go Bombers!

Expand

sorry, this is just wishful thinking.

why do we now trust the board, what about all of the broken promises from over the last 15 years?

do we just forget those lies like nothing happened?

ADO Price at posting: 2.4¢ Sentiment: Hold Disclosure: Held
10 Upvote

1 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

RXL

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 104 more messages in this thread...

First 259 Last

Add ADO (ASX) to my watchlist

(20min delay)
Last 2.2¢		Change -0.001(4.35%)		Mkt cap ! $57.26M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.2¢	$380	17.29K

Buyers (Bids)

No.	Vol.	Price($)
2	1191252	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	8455	2

View Market Depth

No.	Vol.	Price($)
2	1191252	0.021
8	1415497	0.020
10	2127381	0.019
4	357002	0.018
2	64748	0.017

Price($)	Vol.	No.
0.022	8455	2
0.023	642868	9
0.024	741966	3
0.025	578846	8
0.026	83915	2

Last trade - 10.00am 04/10/2024 (20 minute delay)

ADO (ASX) Chart

Ann: AnteoTech $6.4m Capital Raising, page-259

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: AnteoTech $6.4m Capital Raising, page-259

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Diamond drilling hits gold at 16.71 g/t for Rox at Paddy's Lode, extending mineralisation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News